Press Release
dsm-firmenich completes €540 million share repurchase program
Kaiseraugst (Switzerland), Maastricht (Netherlands), October 1, 2026
dsm-firmenich, innovators in nutrition, health, and beauty, announces it has completed its €540 million share repurchase program.
On March 12, 2026, the company announced the start of the program for a total amount of €540 million, of which €40 million to cover commitments under the Group’s share-based compensation plans and €500 million to reduce its issued capital.
In accordance with regulations, dsm-firmenich informs the market that during the period from September 28, 2026 up to and including September 30, 2026 a total number of 193,100 shares have been repurchased on its behalf. The shares were repurchased at an average price of €98.62 per share for a total amount of €19.0 million.
This repurchase concludes the share buyback program, with a total number of shares repurchased under this program of 7,169,147 shares at an average price of €75.32 and for a total consideration of €540 million. Of the total, 680,701 shares have been repurchased to cover commitments under the Group’s share-based compensation plans, and 6,488,446 shares have been repurchased for capital reduction purposes.
dsm-firmenich intends to cancel 6,488,446 shares by the end of the first quarter of 2027. This cancellation will reduce the number of issued shares by c. 2.6% from 253,626,947 shares to 247,138,501 shares.
For more detailed information see ‘Daily transaction details Share Repurchase Program announced February 9, 2026’.
For more information, please contact:
dsm-firmenich investor relations enquiries:
Email: investors@dsm-firmenich.com
dsm-firmenich media enquiries:
Email: media@dsm-firmenich.com
About dsm-firmenich
As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for people and the planet. dsm-firmenich is a Swiss company, listed on Euronext Amsterdam and SIX Swiss Exchange, with operations in almost 60 countries and revenues of more than €9 billion for its Continuing Operations following the divestment of Animal Nutrition & Health. With a diverse, worldwide team of nearly 21,000 employees, we bring progress to life every day, everywhere, for billions of people. www.dsm-firmenich.com
Disclaimer
This press release does not constitute or form part of, an offer or any solicitation of an offer for securities in any jurisdiction. This press release may contain forward-looking statements with respect to dsm-firmenich’s future. Such statements are based on current expectations, estimates and projections of dsm-firmenich and information currently available to the company. dsm-firmenich cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. dsm-firmenich has no obligation to update the statements contained in this press release, unless required by law. This communication contains information that qualifies as inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation. The English language version of this press release prevails over other language versions.
Attachment
